Judith Hochman to Risk Assessment
This is a "connection" page, showing publications Judith Hochman has written about Risk Assessment.
Connection Strength
0.059
-
Sex Differences in Clinical Characteristics, Psychosocial Factors, and Outcomes Among Patients With Stable Coronary Heart Disease: Insights from the STABILITY (Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy) Trial. J Am Heart Assoc. 2017 Sep 14; 6(9).
Score: 0.031
-
Multiple Biomarker Approach to Risk Stratification in COVID-19. Circulation. 2021 03 30; 143(13):1338-1340.
Score: 0.010
-
Thrombosis in hospitalized patients with viral respiratory infections versus COVID-19. Am Heart J. 2021 01; 231:93-95.
Score: 0.010
-
Interleukin-6 and the Risk of Adverse Outcomes in Patients After an Acute Coronary Syndrome: Observations From the SOLID-TIMI 52 (Stabilization of Plaque Using Darapladib-Thrombolysis in Myocardial Infarction 52) Trial. J Am Heart Assoc. 2017 Oct 24; 6(10).
Score: 0.008